Volume 15, Issue 3 (Fall 2011)
Physiol Pharmacol 2011, 15(3): 341-350 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini A, Shafiee-Nick R, Parsaee H, Sadeghian H. Inotropic and chronotropic effects of new cilostamide derivatives on isolated rat atria. Physiol Pharmacol 2011; 15 (3) :341-350
URL: http://ppj.phypha.ir/article-1-722-en.html
URL: http://ppj.phypha.ir/article-1-722-en.html
Abstract: (10974 Views)
Introduction: It was shown in a previous study, that MCPIP, a cilostamide derivative, increased atrial contraction
force without changing contraction rate. To improve this property, two new derivatives of cilostamide were synthesized
and their effects on PDE3 activity and isolated rat atria contraction were investigated.
Methods: The inhibitory effect of each compound on PDE3 enzyme was determined. Reserpine-treated rat atria
were separated and suspended in an organ bath containing Krebs-Henseleit buffer. The effects of each compound alone
or in combination with isoprenaline were assessed.
Results: Mc2 and mbc2 inhibited PDE3 activity with a potency lower than cilostamide, while they increased the
contraction force with a higher efficacy (percentage higher than base line, cilostamide=19±3%, P<0.05, mc2= 43±7%
and mbc2=34±5%, P<0.001). The effect of isoprenaline was potentiated by cilostamide and new compounds with
different efficacies (mc2>mbc2>cilostamide). Atrial contraction rate was increased in the presence of cilostamide or
isoprenaline, but was not changed with synthetic compounds. Furthermore, the effect of isoprenaline on the contraction
rate was inhibited by synthetic compounds (percentage higher than base line, isoprenaline=68±9%, +mc2=6±5% and
+mbc2=36±6%) and was not changed in the presence of cilostamide.
Conclusion: The synthetic compounds induced an increase in the atrial contraction force that was higher than
cilostamide and was not correlated to their PDE3 inhibition. These compounds potentiated the effect of isoprenaline on
the contraction force which excludes the possibility of their inhibitory effect on the receptor. In addition to PDE3
inhibition, other mechanisms are involved in producing the effects of these compounds, which are not clear and needs
further investigation.
Type of Manuscript: Experimental research article |
Subject:
Cardiovascular Physiology/Pharmacology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
